Found 17 matching trials
Empagliflozin and Hepatic Glucose Metabolism PHASE4 the aim of this study is to examine the role of autonomic nervous system in...
Show More Location
Diabetes Division, UTHSCSA
Learn More & Join Trial
Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination PHASE4 The efficacy and safety of a triple-pill combination therapy for advanced t...
Show More Location
Faisalabad clinics
Learn More & Join Trial
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure EARLY_PHASE1 Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce CVD events, inclu...
Show More Location
University of Minnesota
Learn More & Join Trial
Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors PHASE2 Obesity increases the risk of cardiometabolic diseases such as hypertension...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction PHASE3 This study is planned to investigate the impact of Empagliflozin on biomark...
Show More Location
Barmherzige Brüder Eisenstadt
Learn More & Join Trial
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients PHASE4 Chronic hepatitis B (CHB) affects 257million individuals worldwide. In 2017...
Show More Status
Active Not Recruiting
Location
The University of Hong Kong/Queen Mary Hospital
Learn More & Join Trial
Polypill Strategy for Heart Failure With Reduced Ejection Fraction PHASE2 Heart failure with a reduced ejection fraction (HFrEF) represents a signifi...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills PHASE1 The primary objective of this trial is to establish the bioequivalence of t...
Show More Location
Humanpharmakologisches Zentrum Biberach
Learn More & Join Trial
This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood PHASE1 To establish the bioequivalence of one fixed dose combination (FDC) tablet ...
Show More Location
Humanpharmakologisches Zentrum Biberach
Learn More & Join Trial
SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections. N/A In this observational study, 60 subjects with type 2 diabetes (T2D) and eli...
Show More Location
University of Pisa
Learn More & Join Trial